Bridgeway Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bridgeway Capital Management’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$349K	Hold	221,000	–	–	0.01%	897
2025 Q4	$369K	Hold	221,000	–	–	0.01%	883
2025 Q3	$373K	Buy	221,000 +71,000	+47%	+$84K	0.01%	863
2025 Q2	$136K	Sell	150,000 -17,900	-11%	-$10.6K	﹤0.01%	1027
2025 Q1	$75.8K	Sell	167,900 -250,000	-60%	-$147K	﹤0.01%	1083
2024 Q4	$210K	Sell	417,900 -338,866	-45%	-$249K	﹤0.01%	997
2024 Q3	$685K	Buy	756,766 +75,000	+11%	+$69.5K	0.01%	779
2024 Q2	$680K	Hold	681,766	–	–	0.02%	792
2024 Q1	$1.01M	Sell	681,766 -100,000	-13%	-$113K	0.02%	741
2023 Q4	$852K	Hold	781,766	–	–	0.02%	794
2023 Q3	$922K	Hold	781,766	–	–	0.02%	727
2023 Q2	$1.1M	Hold	781,766	–	–	0.03%	706
2023 Q1	$1.17M	Hold	781,766	–	–	0.03%	690
2022 Q4	$915K	Buy	781,766 +540,100	+223%	+$681K	0.02%	748
2022 Q3	$273K	Sell	241,666 -152,700	-39%	-$224K	0.01%	1069
2022 Q2	$623K	Buy	394,366 +379,700	+2,589%	+$501K	0.01%	833
2022 Q1	$23K	Sell	14,666 -202,600	-93%	-$314K	﹤0.01%	1303
2021 Q4	$532K	Sell	217,266 -11,000	-5%	-$25.7K	0.01%	968
2021 Q3	$575K	Sell	228,266 -368,161	-62%	-$945K	0.01%	993
2021 Q2	$1.7M	Sell	596,427 -46,712	-7%	-$121K	0.03%	684
2021 Q1	$1.51M	Sell	643,139 -37,700	-6%	-$90.5K	0.03%	717
2020 Q4	$1.2M	Buy	680,839 +96,300	+16%	+$135K	0.03%	709
2020 Q3	$547K	Buy	584,539 +126,479	+28%	+$112K	0.01%	852
2020 Q2	$399K	Sell	458,060 -70,979	-13%	-$62.5K	0.01%	935
2020 Q1	$438K	Hold	529,039	–	–	0.01%	810
2019 Q4	$471K	Hold	529,039	–	–	0.01%	1016
2019 Q3	$518K	Hold	529,039	–	–	0.01%	947
2019 Q2	$582K	Hold	529,039	–	–	0.01%	929
2019 Q1	$693K	Buy	529,039 +288,339	+120%	+$359K	0.01%	896
2018 Q4	$220K	Buy	240,700 +22,730	+10%	+$34.8K	﹤0.01%	1201
2018 Q3	$448K	Buy	+217,970	New	+$458K	﹤0.01%	1171
2014 Q4	–	Sell	-153,390	Closed	-$389K	–	1482
2014 Q3	$389K	Hold	153,390	–	–	0.01%	1193
2014 Q2	$378K	Hold	153,390	–	–	0.01%	1202
2014 Q1	$407K	Hold	153,390	–	–	0.01%	1165
2013 Q4	$446K	Hold	153,390	–	–	0.01%	1095
2013 Q3	$470K	Hold	153,390	–	–	0.02%	1068
2013 Q2	$490K	Buy	+153,390	New	+$491K	0.02%	952

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return